Ventana Medical Systems (Ventana), a member of the Roche Group, has announced that its Ventana HER2/neu (4B5) rabbit monoclonal primary antibody assay is now a companion diagnostic for detecting HER2 protein expression for patients who, in ...
Tags: Ventana, Medical Systems
Ventana Medical Systems, a member of the Roche Group, has obtained the US Food and Drug Administration’s (FDA) 510(k) approval for its Companion Algorithm ER (SP1) image analysis algorithm used with the Ventana iScan Coreo scanner ...
Tags: Breast Cancer, Analysis Algorithm
Ventana Medical Systems,a member of the Roche Group, and pharmaceutical company Boehringer Ingelheim (BI) have entered into a collaboration agreement for the development of companion diagnostic tests for BI oncology programs. Companion ...
Ventana Medical Systems, a member of the Roche Group, has launched a new fully-automated staining technique that allows researchers to visualize miRNAs and proteins related to cancer in the same section of tumor tissue. Detection of ...
Tags: Ventana, staining technique, cancer detection, miRNAs
Ventana Medical Systems, a member of the Roche Group, has introduced a fully-automated staining technique, which helps researchers to examine miRNAs and proteins related to cancer in the same section of tumor tissue. Detecting miRNAs and ...
Tags: Ventana Medical Systems, miRNAs, proteins related to cancer
Ventana Medical Systems has received FDA approval for the application of its INFORM HER2 Dual ISH DNA Probe cocktail assay (HER2 Dual ISH) on the BenchMark ULTRA automated slide staining platform. The BenchMark XT instrument, the HER2 ...